Among patients administered extracts for a period of at least one year, 51 percent experienced a significant decline in seizure frequency.
Topic: CBD
Investigators reported, “Our results revealed significant improvements in [the] overall … scores of the ASD participants, … particularly [among] those with more severe initial symptoms.”
“Cannabidiol should be considered as a treatment option in managing symptoms related to autism,” investigators concluded.
“These findings suggest that CBD could be an alternative to opioids for the treatment of arthritic pain,” authors concluded.
“It is incumbent upon manufacturers to … improve label accuracy through a commitment to frequent and thorough independent testing procedures.”
“CBD attenuated early symptoms of chemotherapy-induced peripheral neuropathy with no major safety concerns,” the study’s authors concluded.
“By the end of treatment, the number of participants rated as markedly or severely ill had decreased from 17 to 5,” investigators reported.
Of the 89 products that provided information regarding the percentage of CBD available in them, only 24 percent provided accurate data.